Precipio Launches Covid-19 Antibody Test in its CLIA laboratory
04 août 2020 10h45 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has completed the internal validation of the FDA-approved COVID-19...
Interpace Biosciences Announces First Quarter 2020 Financial and Business Results
25 juin 2020 16h59 HE
|
Interpace Biosciences, Inc.
First Quarter Net Revenue Improved Over 53% to $9.2 Million Launching COVID-19 Serology Testing Continues to Integrate Service Offerings and Streamline Costs Conference Call and Webcast Thursday...